View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Livio Luyten ... (+4)
  • Livio Luyten
  • Michiel Declercq
  • Thibault Leneeuw
  • Wim Hoste
Wim Hoste
  • Wim Hoste

Solvay Taking a more cautious stance, lowering target price

Increased pressure in the soda ash market prompts us to take a more conservative approach with regards to contract terms for the coming years, resulting in a reduction of our group EBITDA forecasts for 2026-2028 by between 6-11%. The dividend policy of a stable to increasing dividend from a € 2.43 base looks increasingly generous as servicing the dividend representing the vast majority of current FCF generation, limiting the group's ability to pursue other growth initiatives. Despite the attract...

Stijn Demeester
  • Stijn Demeester

Solvay/Attractive yield, limited near-term catalysts/HOLD (previously ...

We trim our target price for Solvay to €26 per share (from €30) on the back of lower estimates and downgrade our recommendation from Buy to HOLD. Solvay trades at an attractive dividend yield but otherwise offers too few near-term share price catalysts given ongoing headwinds in some of its core segments.

Solvay SA: 1 director

A director at Solvay SA bought 1,000 shares at 24.900EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Participation notifications by Morgan Stanley

Participation notifications by Morgan Stanley  Press release                                                                 Regulated information Brussels, January 20, 2026, 17:45 CET In line with Belgian transparency legislation (Law of May 2, 2007), Morgan Stanley recently sent to Solvay the following transparency notifications indicating that they crossed the threshold of 3%. Here is a summary of the notifications: Date on which the threshold is crossedVoting rights after the transactionEquivalent financial instruments after the transactionTotalDecember 23, 20250.00%-0.00%January 9,...

 PRESS RELEASE

Notifications de participation par Morgan Stanley

Notifications de participation par Morgan Stanley Communiqué de presse                                                         Information réglementée Bruxelles, le 20 janvier 2026 - 17h45 CET Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), Morgan Stanley a envoyé récemment à Solvay les notifications de transparence suivante indiquant avoir franchi le seuil de 3%. Voici un résumé des notifications: Date de dépassement de seuilDroits de voteInstruments financiers équivalentsTotal23 décembre 20250,00%-0,00%9 janvier 20260,04%3,16%...

 PRESS RELEASE

Participatiemeldingen van Morgan Stanley

Participatiemeldingen van Morgan Stanley Persbericht                                                          Gereglementeerde informatie Brussel, 20 januari 2026 - 17u45 CET In overeenstemming met de Belgische transparantiewetgeving (Wet van 2 mei 2007) heeft Morgan Stanley onlangs de volgende transparantiekennisgevingen naar Solvay gestuurd om aan te geven dat ze de drempel van 3% heeft overschreden. Hier is een samenvatting van de bewegingen: Datum waarop de drempel werd overschredenStemrechtenAan stemrechten gelijkgestelde financiële instrumentenTotaal23 december 20250,00%-0,00%9 ja...

 PRESS RELEASE

Participation notification by Morgan Stanley

Participation notification by Morgan Stanley Press release                                                                  Regulated information Brussels, January 6, 2026, 17:45 CET  In line with Belgian transparency legislation (Law of May 2, 2007), Morgan Stanley recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%.  Here is a summary of the notification  Voting rights after the transactionEquivalent financial instruments after the transactionTotalPrevious0.13%3.17%3.30%New0.00%-0.00% The notification, dated December 31, 2025...

 PRESS RELEASE

Notification de participation par Morgan Stanley

Notification de participation par Morgan Stanley Communiqué de presse                                                                 Information réglementée Bruxelles, le 6 janvier 2026 - 17h45 CET Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), Morgan Stanley a envoyé récemment à Solvay la notification de transparence suivante indiquant avoir franchi le seuil de 3%.  Voici un résumé de la notification:   Droits de vote après la transaction Instruments financiers équivalents après la transaction Tota...

 PRESS RELEASE

Participatiemelding van Morgan Stanley

Participatiemelding van Morgan Stanley Persbericht                                                                 Gereglementeerde informatie Brussel, 6 januari 2026 - 17u45 CET In overeenstemming met de Belgische transparantiewetgeving (Wet van 2 mei 2007) heeft Morgan Stanley onlangs de volgende transparantiekennisgeving naar Solvay gestuurd om aan te geven dat ze de drempel van 3% heeft overschreden.  Hier is een samenvatting van de beweging:  Stemrechten na de transactieAan stemrechten gelijkgestelde financiële instrumenten na de transactieTotaalVorige0,13%3,17%3,30%Nieuw0,00%-0,00%...

Guy Sips ... (+4)
  • Guy Sips
  • Hilde Van Boxstael
  • Mathijs Geerts Danau
  • Wim Lewi
Hilde Van Boxstael ... (+3)
  • Hilde Van Boxstael
  • Mathijs Geerts Danau
  • Wim Lewi
Mathijs Geerts Danau
  • Mathijs Geerts Danau

Sequana Medical New DSR patent improves value of program

Sequana announces granting of a key additional methods and formulation patent for DSR. This patent increases durability and expands protection of Sequana's DSR IP, thereby improving its value. We note that the patent provides additional time for Sequana to secure dedicated financing to advance DSR toward the randomized controlled portion of the MOJAVE clinical study. We reiterate our BUY rating.

 PRESS RELEASE

Solvay Financial Calendar 2026

Solvay Financial Calendar 2026 Press release                                                                  Regulated information Brussels, December 17, 2025, 5.45pm CET Solvay today publishes its 2026 financial calendar. EventDateInterim dividend: ex-dateJanuary 19, 2026Interim dividend: payment dateJanuary 21, 2026Fourth quarter and full year 2025 earnings February 24, 2026First quarter 2026 earnings May 7, 2026Ordinary General Shareholders’ MeetingMay 12, 2026Second quarter and first half year 2026 earnings July 29, 2026Third quarter and first nine months 2026 earnings November 4, 20...

 PRESS RELEASE

Calendrier financier de Solvay en 2026

Calendrier financier de Solvay en 2026 Communiqué de presse                                                                 Information réglementée Bruxelles, le 17 décembre 2025 - 17h45 CET Solvay publie aujourd’hui son calendrier financier pour 2026. ÉvénementDateDividende intérimaire: ex-date19 janvier 2026Dividende intérimaire: date de paiement21 janvier 2026Résultats du quatrième trimestre et de l’année 202524 février 2026Résultats du premier trimestre 20267 mai 2026Assemblée générale ordinaire des actionnaires12 mai 2026Résultats du deuxième trimestre et du premier semestre 202629 j...

 PRESS RELEASE

Financiële kalender van Solvay in 2026

Financiële kalender van Solvay in 2026 Persbericht                                                             Gereglementeerde informatie Brussel, 17 december 2025, 17u45 CET Solvay publiceert vandaag zijn financiële kalender voor 2026. Evenement Datum Interimdividend: ex-coupon datum 19 januari 2026 Interimdividend: datum van betaling 21 januari 2026 Resultaten voor het vierde kwartaal en jaar 2025 24 februari 2026 Resultaten eerste kwartaal 2026 7 mei 2026 Gewone algemene aandeelhoudersvergadering  12 mei 2026 Resultaten tweede kwartaal e...

 PRESS RELEASE

Participation notification by UBS Group AG

Participation notification by UBS Group AG Press release                                                                  Regulated informationBrussels, December 15, 2025, 17:45 CET In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%.  Here is a summary of the notification:  Voting rights after the transactionEquivalent financial instruments after the transactionTotalPrevious0.17%2.88%3.05%New0.17%3.20%3.37% The notification, dated December 10, 2025...

 PRESS RELEASE

Notification de participation par UBS Group AG

Notification de participation par UBS Group AG Communiqué de presse                                                                 Information réglementée Bruxelles, le 15 décembre 2025 - 17h45 CET Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), UBS Group AG a envoyé récemment à Solvay la notification de transparence suivante, indiquant avoir franchi le seuil de 3%.  Voici un résumé de la notification:   Droits de vote après la transaction Instruments financiers équivalents après la transaction Total...

 PRESS RELEASE

Participatiemelding van UBS Group AG

Participatiemelding van UBS Group AG Persbericht                                                                 Gereglementeerde informatie Brussel, 15 december 2025 - 17u45 CET In overeenstemming met de Belgische transparantiewetgeving (Wet van 2 mei 2007) heeft UBS Group AG onlangs de volgende transparantiekennisgeving naar Solvay gestuurd om aan te geven dat ze de drempel van 3% heeft overschreden.  Hier is een samenvatting van de beweging:   Stemrechten na de transactie Aan stemrechten gelijkgestelde financiële instrumenten na de transactie Totaal Vor...

Guy Sips ... (+9)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Wim Hoste
  • Wim Lewi

Morning Notes : ACKB BB, AKZA NA, IBAB BB, ONTEX BB, SEQUA BB, XIOR BB...

: ACKB BB, AKZA NA, IBAB BB, ONTEX BB, SEQUA BB, XIOR BB, DEME BB, ARG FP, ZEAL DC

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch